Imperial College London
Alternate

Professor Tom Bourne

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Chair in Gynaecology
 
 
 
//

Contact

 

+44 (0)20 3313 5131t.bourne Website

 
 
//

Location

 

Early pregnancy and acute gynaecologyInstitute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Timmerman:2021:10.52054/FVVO.13.2.016,
author = {Timmerman, D and Planchamp, F and Bourne, T and Landolfo, C and du, Bois A and Chiva, L and Cibula, D and Concin, N and Fischerova, D and Froyman, W and Gallardo, G and Lemley, B and Loft, A and Mereu, L and Morice, P and Querleu, D and Testa, C and Vergote, I and Vandecaveye, V and Scambia, G and Fotopoulou, C},
doi = {10.52054/FVVO.13.2.016},
journal = {Facts Views Vis Obgyn},
title = {ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours.},
url = {http://dx.doi.org/10.52054/FVVO.13.2.016},
volume = {13},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the preoperative diagnosis of ovarian tumours, including imaging techniques, biomarkers and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the preoperative diagnosis of ovarian tumours and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the preoperative diagnosis of ovarian tumours and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.
AU  - Timmerman,D
AU  - Planchamp,F
AU  - Bourne,T
AU  - Landolfo,C
AU  - du,Bois A
AU  - Chiva,L
AU  - Cibula,D
AU  - Concin,N
AU  - Fischerova,D
AU  - Froyman,W
AU  - Gallardo,G
AU  - Lemley,B
AU  - Loft,A
AU  - Mereu,L
AU  - Morice,P
AU  - Querleu,D
AU  - Testa,C
AU  - Vergote,I
AU  - Vandecaveye,V
AU  - Scambia,G
AU  - Fotopoulou,C
DO  - 10.52054/FVVO.13.2.016
PY  - 2021///
SN  - 2032-0418
TI  - ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours.
T2  - Facts Views Vis Obgyn
UR  - http://dx.doi.org/10.52054/FVVO.13.2.016
UR  - https://www.ncbi.nlm.nih.gov/pubmed/34107646
UR  - https://fvvo.eu/in-press/esgo-isuog-iota-esge-consensus-statement-on-preoperative-diagnosis-of-ovarian-tumours/
UR  - http://hdl.handle.net/10044/1/89764
VL  - 13
ER  -
Download